Editorial Praises High Court’s Human DNA Patent Ruling

A Contra Costa Times editorial argues that the U.S. Supreme Court's unanimous ruling last week that biotechnology companies "cannot patent parts of naturally occurring human genes" ... "recognized the difference between discovery and innovation." It concludes, "The court's reasonable decision should be a boon for medical science and the common good."

• "Contra Costa Times Editorial: Supreme Court's Decision on DNA Patent Right on Target" (Contra Costa Times, 6/14).